Suppliers / TAPI Czech Industries s.r.o

TAPI Czech Industries s.r.o

Czech Republic Updated 9 July 2026

TAPI Czech Industries s.r.o is an API manufacturer based in Czech Republic. It holds 16 valid CEPs across a filed portfolio of 14 molecules.

0
active US DMFs
16
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
S.R.O. Opava, Czech Republic Not on file
Czech Republic, Czech Republic 3031869541

What they file, and where

Molecule Regulators Docs
Buprenorphine EDQM 2
Milk Thistle Dry Extract EDQM 2
Bromocriptine Mesilate EDQM 1
Cabergoline EDQM 1
Cyclosporine EDQM 1
Dihydroergotamine Mesilate EDQM 1
Ergoloid Mesylate EDQM 1
Ergometrine EDQM 1
Ergotamine EDQM 1
Galantamine Hydrobromide EDQM 1
Show all 14 molecules on file
Methylergometrine EDQM 1
Mycophenolate Mofetil EDQM 1
Nicergoline EDQM 1
Pergolide Mesilate EDQM 1

Also appears on these molecule pages

Cabergoline API Ciclosporin API Mycophenolate Mofetil API

Comparing suppliers?

Choose your molecules and target markets. TAPI Czech Industries s.r.o comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability